MKI67 and type 2 diabetes mellitus: In our MIN6 T1D/T2D stressor models, verapamil treatment improved β-cell viability/proliferation in a dose- and time-dependent manner, as supported by increased expression of Ki67/H3 proliferation markers and evidence of actively replicating β-cells in the G2/M phase.